Company / Gross Margin
MAXCYTE, INC. Gross Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
81.2%
FY2025
5-year range
81.2% / 89.2%
FY2021-FY2025
Trend
-8.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin remained relatively stable over the past 5 years, with values between 81.2% and 89.2%.
Based on SEC 10-K filings.
81.2% in FY2025 with a 3-year CAGR of -7.3%.
Declined from 88.5% to 81.2% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -7.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 8.3% year-over-year.
- Peak gross margin was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 81.2% | -8.3% |
| FY2024 | 88.5% | +0.0% |
| FY2023 | 88.5% | +0.0% |
| FY2022 | 88.5% | -0.9% |
| FY2021 | 89.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026